Key result
Hybrid coronary revascularization yielded a 98.1% mean overall survival rate and significantly lower in-hospital MACCE rates compared with conventional CABG.
Why the study?
Does hybrid coronary revascularization improve clinical outcomes and reduce complications compared to conventional CABG in patients with multivessel coronary artery disease?
Does hybrid coronary revascularization improve clinical outcomes and reduce complications compared to conventional CABG in patients with multivessel coronary artery disease?
Hybrid coronary revascularization appears to be a safe, feasible, and cost-effective alternative to conventional CABG for selected patients with multivessel coronary artery disease, offering shorter hospital stays and lower in-hospital complication rates.
No takes yet. Share an insight, caveat, or question.
Supports HCR consideration in selected multivessel CAD; extends systematic evidence for its role versus CABG.
Verhaegh et al. (2013) conducted a review in Multivessel coronary artery disease (n=970). Hybrid coronary revascularization vs. On-pump and off-pump coronary artery bypass grafting (CABG) was evaluated on Mean overall survival rate. Hybrid coronary revascularization yielded a 98.1% mean overall survival rate and significantly lower in-hospital MACCE rates compared with conventional CABG.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: